1982-1984 Assistant Clinical Professor, SUNY Upstate Medical Center

1982-1984 Attending, Crouse-Irving Memorial Hospital, SUNY Upstate Medical Center, Syracuse, New York

1982-1984 General Internist, Syracuse Community Health Center, Syracuse, NY

1982-1984 Surgeon, Commissioned Corps, United States Public Health Service

1987- Active Staff, The Johns Hopkins Hospital

1987-1988 Director, Clinical Track of the Preventive Medicine Residency, The Johns Hopkins University School of Hygiene and Public Health

1987-1988 Instructor, Medicine, Joint Appointment Epidemiology, and Health Policy and Management, The Johns Hopkins University School of Medicine

1988-1992 Assistant Professor, Medicine, Joint Appointment Epidemiology, and Health Policy and Management, The Johns Hopkins University School of Medicine

1988- Director, The Precursors Study (A prospective study of 1,337 Johns Hopkins University Medical Students started in 1946)

1992-1997 Associate Professor, Medicine, Joint Appointment Epidemiology, and Health Policy and Management, The Johns Hopkins University School of Medicine

1994-1996 Acting Director, Division of Internal Medicine, Department of Medicine, The Johns Hopkins University School of Medicine.

1996-2002 Director, Division of General Internal Medicine, Department of Medicine, The Johns Hopkins University School of Medicine.

1996-2001 Associate Director for General Medicine, Department of Medicine, The Johns Hopkins University School of Medicine

1996-1997 Interim Director, The Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Medical Institutions

1998 Professor of Medicine, The Johns Hopkins University School of Medicine, Joint Appointment Epidemiology, and Health Policy and Management

2000-2001 Interim Director, Department of Medicine, The Johns Hopkins University School of Medicine

2000-2001 Interim Physician-in-Chief, The Johns Hopkins Hospital

2001-2005 Vice Dean for Clinical Investigation, The Johns Hopkins University School of Medicine

2005-present Dean, Johns Hopkins Bloomberg School of Public Health

Hypertension, Renal Failure, Precursors Study, Kidney Disease, Cardiovascular, Epidemiology, Genetic Markers, Health Policy and Management

1974 B.S., Magna Cum Laude

1973-1974 Juniata College Honor Society

1972-1974 Beta Beta Beta National Biological Honor Society; President, Juniata College Chapter, 1974

1971-1974 Juniata College Philadelphia Area Alumni Scholar

1985-1988 Post-doctoral Trainee, NIH Training Grant in Behavioral Medicine and Cardiovascular Disease

1987 The John Hume II Award for Academic Excellence and Professional Promise, The Johns Hopkins University School of Hygiene and Public Health

1988 Fellow, Fourteenth 10-Day Seminar on the Epidemiology and Prevention of Cardiovascular Diseases sponsored by the American Heart Association

1991-1996 Established Investigator, American Heart Association

1993 Delta Omega National Public Health Honorary Society, Alpha Chapter

1997 Fellow, American College of Physicians

1999 Raine Visiting Professor, The University of Western Australia

2003 David M. Levine Excellence in Mentoring Award

2004 Champion of Public Health Award

Astor BC, Eustace JA, Klag MJ, Powe NR, Longenecker JC, Fink NE, Marcovina SM, Coresh J. Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: The CHOICE Study. Kidn Internatl 2002 61(3):1115-1123

Berenholtz SM, Pronovost PJ, Mullany D, Garrett E, Ness PM, Dorman T, Klag MJ Predictors of transfusion for spinal surgery in Maryland, 1997-2000. Transfusion 2002; 42:183-9

Houston TK, Meoni LA, Ford DE, Brancati FL, Cooper LA, Levine DM, Liang K-Y, Klag MJ. Sports ability in young men and incidence of cardiovascular disease. Am J Medicine 2002:112:689-695.

Chang PP, Ford DE, Meoni LA, Wang N-Y, Klag MJ. Anger in young men and subsequent premature cardiovascular disease: The Precursors Study. Arch Intern Med 2002;162:901-906.

Klag MJ, Wang NY, Meoni LA, Brancati FL, Cooper L, Liang KY, Young JH, Ford DE. Coffee Intake and Risk of Hypertension: The Johns Hopkins Precursors Study. Arch Intern Med 2002;162:657-662.

Jee SH, Miller ER III, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. American Journal of Hypertension 2002;15:691-696.

Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, Fink NE, Coresh J, Powe NR, Klag MJ. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidn Dis 2002;39:324-36.

Curtin RB, Klag MJ, Bultman DC, Schatell D. Renal rehabilitation and improved patient outcomes in Texas Dialysis Facilities. Am J Kidn Dis 2002 Aug;40(2):331-8.

Muntner P, Garrett E., Klag MJ, Burt VL, Coresh J. Trends in Stroke Prevalence Between 1973 and 1991 in the United States Population 25-74 Years of Age. Stroke 2002;33(5):1209-13.

Muntner P, Coresh J, Klag MJ, Whelton PK, Perneger TV. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: An analysis of shared risk factors. Am J Kidn Dis 2002;40:323-30.

Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin AA, Klag M. Traditional cardiovascular disease risk factors in dialysis patients compared to the general population: the CHOICE Study. J Am Soc Nephrol 2002;13:1918-27.

Kinchen KS, Sadler JH, Fink NE, Brookmeyer R, Klag MJ, Levy AS, Powe NR. Timing of specialist evaluation for chronic kidney disease and mortality. Ann Int Med 2002; 137:479-486.

Longenecker JD, Klag MJ, Marcovina SM, Powe NR, Fink NE, Levey AS, Giaculli F, Coresh J. Small apolipoprotein(a) size predicts total mortality in end-stage renal disease (ESRD): the CHOICE Study. Circulation 2002;106;2812-2818.

Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 2002; 11:2776-2782.

Golden S, Wang NY, Klag MJ, Meoni LA, Brancati FL. Blood Pressure in Young Adulthood and the Risk of Type 2 Diabetes Mellitus in Middle Age. Diabetes Care 2003;4:1110-1115.

Longenecker JC, Coresh J, Marcovina SM, Powe NR, Levey AS, Giaculli F, Fink NE, Klag MJ. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: the Choice for Healthy Outcomes in Caring for ESRD (CHOICE) study. AJKD 2003;42:108-16.

Muntner P, Coresh J, Powe NR, Klag MJ. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol. 2003 Jun;14(6):1568-77.

Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003 Nov;14(11):2934-41.

Gallo JJ, Straton JB, Ford DE, Klag MJ, Meoni LA, Sulmasy DP Life-sustaining treatments: What do physicians want and do they express their wishes to others? J Am Geriatr Soc. 2003 Jul;51(7):961-9.

Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, King K, Klag MJ, Molony DA, Flack JM. Early detection of kidney disease in community settings: The Kidney early evaluation program (KEEP). Am J Kidney Dis 2003;42:22-35.

Muntner P, Coresh J, Klag MJ, Whelton PK, Perneger TV. Exposure to radiologic contrast media and an increased risk of treated end-stage renal disease. Am J. Med Sci 2003; Dec;326(6):353-9.

Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA. 2004;291:451-459.

Plantinga LC, Fink NE, Sadler JH, Levey AS, Levin NW, Rubin HR, Coresh J, Klag MJ, Powe NR. Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol. 2004 Jan;15(1):210-8.

Muntner P, Coresh J, Klag MJ, et al. The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease. J Am Soc Nephrol 2003;14:1568-77.

Lucas KE, Rowe PC, Coresh J, Klag MJ, Meoni LA, Ford DE. Prospective association between hypotension and idiopathic chronic fatigue. Journal of Hypertension 2004;11:691-695

Straton JB, Casarett D, Wang N-Y, Meoni LA, Ford DE, Klag MJ. Physical functioning, depression, and preferences for treatment at the end of life: The Johns Hopkins Precursors Study. J Am Geriatr Soc 2004 Apr;52(4):577-82.

Fox C, Longenecker JC, Powe N, Klag MJ, Fink NE, Parekh R, Coresh J for the CHOICE Study. Undertreatment of Hyperlipidemia in a Cohort of United States Kidney Dialysis Patients. Clinical Nephrology 2004 May;61(5):299-307.

On behalf of the Family Investigation of Nephropathy and Diabetes Research Group, Knowler WC, Coresh J, Elston RC, Freedman BI, Iyengar SK, Kimmel PL, Olson JM, Plaetke R, Sedor JR, Seldin MF. The Family Investigation of Nephropathy and Diabetes (FIND): Design and Methods. Journal of Diabetes and its Complications 2005;19:1-9.

Torre DM, Wang N-Y, Meoni LA, Young JH, Klag MJ, and Ford DE. Suicide compared to other causes of mortality in physicians. Suicide and Life-Threatening Behavior 2005;35(2):146-153.

Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J . Type of vascular access and survival among incident hemodialysis patients: the CHOICE Study. J Am Soc Neph 2005;16(5):1449-1455.

Plantigna LC, Jaar BG, Fink NE, Sadler JH, Levin NW, Coresh J, Klag MJ, and Powe NR. Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets. Int J Qual Health Care 2005;17(2):115-21.